Introduction
Glial tumors account for the largest percentage of primary tumors of the central nervous system. In their most malignant and prevalent form these tumors are classi®ed as glioblastoma multiforme (GBMs) with an average patient survival of approximately 1 year. The vast majority of GBM examined by either karyotypic or molecular analyses have shown a multiplicity of chromosomal aberrations including ampli®cation of chromosome 7, and regional deletions or monosomies of chromosomes 9p21, 10p, 10q, 11p15, 13q13, 17p13, 19, and 22 (Bigner et al, 1988; Fults et al, 1989 Fults et al, , 1990 James et al, 1988 James et al, , 1991 Rasheed et al, 1992 Rasheed et al, , 1995 Ransom et al, 1992; Ritland et al, 1995) . The most common chromosomal alteration involves an apparent grade-speci®c loss of chromosome 10 alleles associated with high grade GBMs. Frequently, an entire copy of chromosome 10 is lost in GBM but only rarely in the histologically lower grade gliomas (James et al, 1988; Fults et al, 1990; Rasheed et al, 1992) . These observations suggest that chromosome 10 may harbor one or more tumor suppressor genes whose loss of function is involved in the progression of gliomas from low to high grade. The ampli®cation and alteration of epidermal growth factor receptor (EGF-R) on chromosome 7 has been shown to occur predominantly during the progression to GBM and to be associated with loss of chromosome 10 (Fults and Pedone, 1993; Wong et al, 1987; von Diemling et al, 1992) .
To investigate the possible biological role(s) of chromosome 10 alteration in GBM, we had previously transferred a single copy of chromosome 10 into a human GBM-derived cell line, U251, and showed a suppression of the in vitro and in vivo tumorigenic properties of the hybrid cells compared to those of the parental cells (Pershouse et al, 1993) . In addition, chromosomal fragmentation was used to map at least two tumor suppressive loci on chromosome 10, one each on the short and long arms (Steck et al, 1995) . Recently, our laboratory and Parsons and co-workers have identi®ed a candidate tumor suppressor gene (MMAC1/PTEN) at 10q23.3 that is altered in a large number of gliomas and several other human cancers . MMAC1 is a dual speci®city phosphatase (Myers et al, 1997) with homology to the cytoskeleton proteins tensin and auxillin, although its role in tumor suppression and signal transduction is currently unknown. An additional candidate tumor suppressor gene distal to this region, DMBT1 (10q25.3-26.1), has recently been identi®ed and found to be deleted in malignant brain tumors (Mollenhauer et al. 1997) . However, the precise biological role for DMTB1 remains to be elucidated. In this study, we have generated microcell hybrid cells that are phenotypically suppressed, express MMAC1 and fortuitously lack an intact chromosome 10 in the parental cells. Furthermore, a subtractive hybridization was performed between the GBM cells and their nontumorigenic hybrid counterparts to isolate gene sequences which are differentially expressed and which may be directly or indirectly involved in glioma oncogenesis.
Results

Generation and characterization of hybrid cells containing chromosome 10
To assess the biological and molecular alterations associated with the loss of intact chromosome 10 in human gliomas, a chromosome 10 was introduced into LG11 cells using microcell-mediated transfer to generate LG11.S3 hybrid cells. The transfer of chromosome 10 into LG11 cells was documented by karyotyping of LG11.S3 cells and showing that an intact copy of chromosome 10 was present. This is in contrast to LG11 cells which lack an intact homologue of chromosome 10 ( Figure 1A, B) . The status of chromosome 10 in LG11 cells was also examined by chromosome painting of LG11 metaphases with chromosome 10-speci®c inter-alu-PCR products and allelotyping. Several shortened chromosome 10 fragments and small unidenti®able marker chromosomes, half of which contained chromosome 10 material, were observed ( Figure  1C ). Allelotyping of LG11 cells and ®broblasts derived from the same patient revealed loss of heterozygosity for every informative polymorphic probe examined for chromosome 10 suggesting that LG11 cells lost one copy of chromsome 10 and duplicated the remaining fragmented copy. The breakpoint on chromosome 10 was partially mapped to 10q24-25 by¯uorescence in situ hybridization of YAC clones. This break occurred near (*10 cM) but not at the MMAC1 locus, even though a homozygous deletion was shown to occur within this gene Figure 2 ). The morphology of LG11.S3 cells appeared more`astrocytic' (i.e. astrocytic-like processes present at low cell density, seldom observed in LG11 cells, Figure 2 ). LG11.S3 cells exhibited a signi®cantly reduced ability to proliferate under anchorage-independent conditions in contrast to parental LG11 cells (12+5 colonies versus 967+135 colonies per 10 000 cells seeded; Figure 3) .
Furthermore, the diameter of any colony that did form was signi®cantly smaller for LG11.S3 than LG11 cells (325+60 mm versus 75+25 mm) similar to that seen for U251 hybrids (Steck et al, 1995) . The LG11.S3 cells failed to form tumors when injected subcutaneously into nude mice (0 tumors/12 mice; latency414 months) in contrast to LG11 cells (11 tumors/11 mice; latency of 87 days for 0.5 cm 3 tumors). Western blot analysis showed that the MMAC1 gene product was expressed in the suppressed LG11.S3 cells but not the parental cells, indicating retention of function following the microcell-mediated chromosome transfer ( Figure  4 ).
Subtractive hybridization
To identify gene products whose expression may be altered following the transfer of an intact chromosome 10, subtractive hybridization was performed using cDNA synthesized from the suppressed LG11.S3 cells and mRNA isolated from parental LG11 cells. Two rounds of subtractive hybridization were performed and the percentage of single stranded cDNA recovered between the ®rst and second round was calculated. An increase (from 14.5 ± 60%) in this population of cDNA indicated enrichment of differentially expressed cDNA. The resulting unhybridized portion of LG11.S3 cDNA was determined to be approximately 0.9 mg, representing 9% of the starting cDNA, suggesting that the single-stranded cDNA pool had been enriched approximately tenfold. Subsequent tertiary screening of an LG11.S3 cDNA library with radiolabeled subtracted probe resulted in the identi®cation of 61 differentially expressed clones (average size *380 bp, range 170 ± 870 bp).
Single-pass sequences of the clones were obtained and searched against expressed sequence tag (dbEST) and genomic databases using the BLAST search algorithm (Khan et al, 1992; Altschul et al, 1990) . Nucleic acid homologies greater than 95% (over an average of 200 bp) were considered to be indicative of identical genes. Mitochondrial-encoded genes accounted for the majority (54%) of the subtracted clones. Other known gene products included b-actin, aldolase C, ribosomal subunits L7 and L27, and apoferritin light chain. Novel gene products (23 independent clones) comprised 37% of the isolated clones. The novel sequences, with partial homology (50 ± 95%) over at least 50 bp, are listed in Table 1 . Four novel clones failed to identify any signi®cant matches through the BLAST search program, with six clones showing a partial homology to alu repeat elements (Table 1) .
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Figure 4 Western blot of cell extracts (75 mg) from:
LG11 and PC-3 cells, which show no MMAC1 expression due to homozygous gene deletion;
LG11.S3 and HT-29 cells, which express the MMAC1 gene product is detected by an anti-MMAC1 antiserum generated against the C-terminal region of the protein.
The arrow (left) depicts the MMAC1 protein and the molecular size is denoted on the right. a Homologies determined over an average of 100 bp. b Nucleic acid sequence homology over at least 50 bp as determined by BLAST analysis.
c The expression of the messenger RNA was detected by Northern blotting and densitometric analysis from U251 (P; parental) and a suppressed clone (S; suppressed) and LG11 (P) and LG11.S3 (S). Quantitation of the mRNA levels was:-not detected; +: barely detectable; +: detectable; ++: medium abundance; and +++: highly expressed, compared to GAPDH. d nd: no message detected.
e The presence of alu related sequence precluded any signi®cant homology searches.
The expression of all non-mitochondrial cDNA clones was assessed by Northern blot analysis using RNA isolated from LG11, LG11.S3 and U251 tumorigenic glioma cells and its chromosome 10 containing suppressed counterparts (Pershouse et al, 1993) . The use of two glioma model systems (each with parental tumorigenic cells and suppressed hybrids containing an inserted chromosome 10) allows for the identi®cation of gene products whose expression is consistently associated with the suppressed phenotypes seen in hybrid cells. The majority of the clones showed a twofold or less difference in expression levels between the parental and suppressed cells and were not analyzed further. Nine clones showed consistently increased expression in the hybrid cells compared with parental cells for at least one of the two hybrid model systems. The expression of clones 14, 20, 29, 35 and 38 was increased in the hybrid cells of the U251 system, however no message was detected in either the parental or hybrid cells of the LG11 model system (Table 1 ). For these clones (which shared homologies with oligodendrocyte myelin glycoprotein, ADMLX transcription factor, a novel fragment containing part of an alu repeat, a chromosome 19q3.3 EST and the insulin receptor, respectively) a signi®cant increase (5threefold) in mRNA levels was observed in the suppressed hybrid cells of the U251 system. In contrast, clone 54 (100% homology to the apoferritin light chain gene) showed an approximately threefold increase in expression in the suppressed cells of the LG11 system, with only negligible increases seen in the U251 system. Three clones in particular showed signi®cant expression changes in both the U251 and LG11 model systems. Clone 43, one of six mitochondrial clones assessed, shared 100% homology with the mitochondrial tRNA (Phe, Val, Leu) gene product, and showed a 2 ± 3-fold increased expression in the chromosome 10-containing hybrid cells from both systems ( Figure 5 ). Clone 33, which exhibited about 70% homology with PDGF-a chain, showed a twofold increase for both suppressed cell types compared to parental cells. However, the greatest differential expression was observed with clone 17, for which Northern analysis identi®ed a 2.6 kb message consistently increased in the respective hybrids relative to parental cells in both model systems (4 ± 5-fold higher than parental U251 cells and 4 ± 10-fold higher than parental LG11 cells) ( Figure 5 ). Sequencing of clone 17 revealed high homology exclusively to an anonymous expressed sequence tag (EST), IB666, previously isolated from an infant brain cDNA library.
RIG-like gene products
The expression pattern and additional characterization of clone 17, subsequently named RIG (regulated in gliomas), have recently been reported . RIG was observed to be expressed mainly in the brain and at signi®cantly lower levels, or not at all, in a number of GBM cell lines and primary tumors compared to normal or low grade astrocytomas. During the cloning of RIG, seven additional clones, representing three independent gene products, were also isolated from fetal and adult brain expression libraries. All three gene products shared a similar *150 bp sequence, but only RIG was completely identical to clone 17. A homologous region (small overlap was 208 ± 260 bp of EST IB666) was found in the 3' untranslated region of all messages, but the orientation differed between RIG and the remainder of the clones. Three clones, 7-1, 14-1 and 5-6, were partially characterized. Clones 14-1 and 7-1, like RIG, were differentially expressed in GBM cells and their nontumorigenic hybrid counterparts. The expression and size of RIG and 7-1 were almost identical as determined by Northern analysis, even if the region of homology between the transcripts was ®rst removed from probes by digestion with restriction enzymes (Figure 6 ). Clone 14-1 exhibited a larger (M r 3.2 kb) message which was also differentially expressed, while clone 5-6 showed constant expression in all cells assessed by Northern blotting Figure 5 Northern blot analysis of differentially expressed clones using mRNA (10 mg) isolated from LG11, U251, U251.N10.3, U251.N10.6 and LG11.S3 cells. Expression levels and size of clones 43 (a), 54 (b) and 17 (c) are indicated. Expression of each clone was compared with GAPDH hybridized to the same ®lter and quantitated by densitometric analysis. Quantitations represent an average determined from at least three independent Northern blots.
( Table 2 ). The predicted protein products of the clones are presented in Table 2 and Figure 7 . BLAST searches of Genbank revealed homologies between the ESTs previously identi®ed for RIG , while searches for TIGR databases revealed several homologies at both the nucleotide and protein levels (Table 2) . However, no signi®cant homologies or recognizable motifs were noted among the various proteins.
Discussion
This study was undertaken to identify candidate genes which may be involved in, or serve as markers of glioma oncogenesis, and to possibly aid in elucidating the mechanism(s) of phenotypic suppression induced by the presence of a functional chromosome 10. A critical step in this study was the identi®cation of a GBM cell line which lacked an intact chromosome 10, suggesting a potential loss of function, possibly involving a tumor suppressor gene. In fact, LG11 cells are nullisomic at the MMAC1 locus , while the suppressed LG11.3 cells expressed MMAC1. Similarly, U251 cells lost an entire copy of chromosome 10 and the remaining MMAC1 allele was mutated, while the suppressed hybrids expressed a wild-type MMAC1 (Pershouse et al, 1993; Steck et al, 1997 ). An initial step of this study involved the generation and characterization of hybrid cells containing a transferred chromosome 10. Suppression of the in vitro and in vivo tumorigenic phenotype of the parental, tumorigenic cells was demonstrated in the hybrid cells. The LG11.S3 hybrid cells also showed both a distinctive, differentiated morphology at low cell densities as well as an enhanced response to density-dependent inhibition of growth. However, the exponential growth rate was similar to that of a Sequence determined from an individual clone (5-6) or from overlapping clones (7-1, 14-1). b Relative migration of mRNA determined by Northern blotting.
c Chromosomal location determined by chromosomal mapping panel. RIG was further localized bȳ uorescence in situ hybridization . The chromosomal location of 5-6 could not be determined because of similarly sized mouse or hamster genes.
d Differential expression in parental GBM cells LG11 and U251 and hybrid cells. e ESTs from TIGR database.
7-1 GAPDH -2.6 kb
LG11.S3 U251 U251.N10.3 U251.N10.6 U87 PL-1 U138 FB138 Figure 6 Northern analysis of differentially expressed clones using mRNA isolated from LG11, LG11.S3, U251, U251.N10.3, U251.N10.6, U87, PL-1, U138 and FB138 cells probed with radiolabeled cDNA 7-1 minus any sequence that is homologous with RIG (upper panel); GAPDH (lower panel). U87 and U138 are high grade gliomas, while PL-1 is a low grade glioma with intact chromosome 10s. The differential expression and message size of clone 7-1 (M r *2.6 kb) were similar to the levels of expression observed for RIG for the cells examined. Densitometric quantitation for the ratio of 7-1 to GAPDH for the various cells (left to right) are 0.2, 1.4, 0.3, 1.3, 1.2, 0, 1.3, 0.1 and 1.8 respectively. The GAPDH probed blots were exposed to ®lm for 5 h, while the blot probed with 7-1 was exposed 19 h.
Figure 7
Predicted polypeptide sequences of RIG and RIG-like clones (7-1, 14-1 and 5.6). Similar peptide sequences were identi®ed in searches for TIGR database.
the tumorigenic LG11 cells. This would suggest that a functional chromosome 10 suppressor gene may be involved in determining the differentiation status or oncogenic progression of the cells rather than be associated with a proliferation-related gene product (e.g. p53 or p16). This suggestion is also supported by the identi®cation of gene products, through subtractive hybridization, related to differentiation of glial cells. These included oligodendrocyte myelin glycoprotein (OMGP, identi®ed as two independent clones) and apoferritin, both of which were expressed by differentiated oligodendrocytes but not their precursors (Connor et al, 1994; Williams and Deber, 1993) . The lack of expression of these markers in LG11 cells, but their observed presence in U251 cells may re¯ect cells at different stages of differentiation, as U251 cells express the differentiation marker glial ®brillary acidic protein but LG11 cells do not. Alternatively, the expression of these gene products may re¯ect the cell lineage, as certain precursor glial cells have the capacity to differentiate into astrocytes or oligodendrocytes (Raff et al, 1983) .
The clone with the most profound changes in expression between the parental cells and their suppressed hybrids was clone 17. The full length structure and characterization of this gene, RIG, were recently described . The expression of RIG was signi®cantly downregulated in GBM cells which apparently suffered genetic alterations of chromosome 10. However, the induced expression of RIG in GBM cells appeared to have no detectable biological phenotypic changes (unpublished observation). The identi®cation of several related, and differentially expressed, gene products raises several possibilities. First, while the roles of these gene products are currently undetermined, the demonstration of a consistent downregulation in tumor cells may allow these genes to serve as markers of either glial tumorigenicity, status of MMAC1 function or differentiation. Alternatively, as several independent clones appear to exhibit similar differential expression, it is also possible that their coordinate expression is required to affect some common biological function or activate a particular pathway. Furthermore, certain biological or biochemical changes in cells may go undetected by our subtraction analysis. This is exempli®ed by the reported increase in expression of the anti-angiogenic protein, thrombospondin, in nontumorigenic hybrid cells of the U251 and LG11 system (Hsu et al, 1996) ; despite the known differential expression, thrombospondin was not identi®ed in this current analysis.
However, several other interesting sequences were identi®ed by the subtractive hybridization, including PDGF-a and the insulin receptor. PDGF-a has been shown to be expressed by glioma cells and involve an autocrine growth loop (Nister et al, 1988) . The increased PDGF-a expression observed in adult brain, may be related to the maintenance of glial progenitor cells (Pringle et al, 1989) , or may re¯ect the density of the cultured cells. The insulinlike growth factor and its receptors have also previously been shown to be required for glioma cell proliferation and survival. The expression of various other growth factors was determined for LG11 and LG11.S3 cells as well as for U251 and its suppressed hybrids to determine whether the presence of a functional chromosome 10 would in¯uence expression. No signi®cant changes in the expression of epidermal growth factor receptor, transforming growth factor-a, transforming growth factor b (1 and 2), platelet derived growth factor receptor-b, or c-met were observed (data not shown). The lack of any difference in the expression of these growth factors and their receptors is not surprising given the similar exponential growth rate observed between the parental and suppressed hybrid cells.
Subtractive hybridizations have been previously used to successfully identify genes differentially expressed between two cell populations. The technique has an advantage in that chromosomal localization of target genes is not a prerequisite. The v-src oncogene, T cell receptor, myogenic determination gene (myoD), candidates for the Duchenne type muscular dystrophy gene, and WAF-1 have all been isolated through subtractive hybridizations (Stehelin et al, 1976; El-Deiry et al, 1993; Davis, 1986) . The results from our subtractive hybridization demonstrate differential expression of several classes of gene products, some of which appear to re¯ect the differentiation status of the suppressed cells. Finally, our results are in agreement with previous subtractive hybridizations performed between neoplastic and non-neoplastic cells, in which mitochondrial genes as well as several novel gene products have been implicated in the process of tumorigenesis or differentiation (Vayssiere et al, 1994; Sharp et al, 1992) .
Materials and methods
Cell lines and microcell-mediated chromosome transfer The human glioma cell lines LG, PL-1, and U251 were obtained and cultured as previously described (Yung et al, 1989; Pershouse et al, 1993) . The LG11 clone was obtained from a well-spaced colony of LG cells grown under anchorage-independent conditions. U87MG, PC-3 cells, which are homozygously deleted for MMAC1 and HT-29 cells, which express MMAC1, were obtained from ATCC.
The microcell-mediated chromosomal transfer of chromosome 10 into LG11 cells was performed according to published procedures (Stubble®eld and Pershouse, 1992) . Selection of LG11 cells containing a transferred human chromosome 10 was achieved using an endogenous chromosome 10 gene, adenosine kinase, and has been described (Pang et al, 1989) . Brie¯y, selection was accomplished in the presence of adenosine (5 mM), alanosine (10 mM), uracil (500 mM) and EHNA (10 mM). EHNA and alanosine were obtained from Burroughs Wellcome Co. (Research Triangle Park, NC) and the Drug Synthesis and Chemistry Branch, Division of Cancer Treatment, National Cancer Institute (Bethesda, MD) respectively. LG11 cells were suf®ciently de®cient in adenosine kinase to allow for selection of additional chromosome 10 material containing the adenosine kinase gene. Karyotypic analysis, cellular proliferation, growth in soft agarose, and tumor formation of cells in nude mice were performed as previously described (Pershouse et al, 1993) . Rabbit antisera against MMAC1 were generated using the synthetic peptide SDNEPDHYRYSDFTDS corresponding to residues 370 ± 385 of MMAC1 covalently linked to acrylamide gel. The speci®city of the antisera was demonstrated by examining cells which do or do not express MMAC1 and by using an excess of the peptide (1 mg) to block binding of cellular derived MMAC1. Anti-MMAC1 was detected by anti-rabbit secondary antibody conjugated to peroxidase and visualized by ECL reagent (Amersham, Chicago, IL).
mRNA isolation and cDNA synthesis Total RNA was isolated from cultured cells by adding guanidinium isothiocyanate directly to the tissue culture¯asks after decanting the growth medium (Chirgwin et al, 1979) . Poly A + mRNA, when used, was isolated either by oligodeoxythymidylate chromatography of total RNA samples (Aviv and Leder, 1972) or by the Fast Track mRNA isolation method (Invitrogen Co., San Diego, CA). Reverse transcription was performed using Moloney murine leukemia virus reverse transcriptase (20 U/1 mg mRNA), with trace amounts of [a 32 P]dCTP, and a mixture of oligo-d(T) 12-18 mers and random hexamers. The generation of the complementary second strand was accomplished using RNase H and E. coli DNA polymerase. Second-strand synthesis of subtracted cDNA was initiated by hybridizing an excess of LG11.S3 mRNA to the subtracted cDNA and completed using the methods described above.
Subtractive hybridization and hydroxylapatite chromatography
LG11 mRNA was hybridized with LG11.S3 ®rst-strand cDNA in 0.12 M sodium phosphate (pH 6.8), 0.1% SDS, and 5 mM EDTA in a ®nal volume of 150 ml, denatured at 1008C for 5 min, and then incubated at 658C for 24 h (Sambrook et al, 1989) . Single-stranded cDNA molecules were separated from RNA and double-stranded molecules using hydroxylapatite chromatography (Bio-Rad Lab., Richmond, CA) performed at 658C. The singlestranded products were then subjected to a second round of subtractive hybridization at a ratio of 20 : 1 (LG11 : LG11.S3), followed by hydroxylapatite chromatography.
Library construction and screening Double-stranded LG11.S3 cDNA was cloned into the Lambda Zap II vector (Stratagene, La Jolla, CA) and packaged using Giga-Pack Gold II packaging extract (Strategene). The unampli®ed titer of this library was 10 6 p.f.u./ml and it was screened using duplicate plaque lifts. Prehybridization was performed for 3 ± 18 h at 658C in 66SSC, 26Den-hardt's and 100 mg/ml sonicated salmon sperm DNA. Hybridization of ®lters with radioactivity labeled probes was performed overnight in the same solution. The ®lters were washed in 66SSC, 1.0% SDS for 1 h at 658C and, if needed, in 26SSC, and 0.1% SDS for 20 min at 658C. Exposure time, with intensifying screens, ranged from overnight to 5 days at 7808C.
Inserts from the positive tertiary clones were ampli®ed directly from plaques using primers against adjacent Bluescript T3/T7 promoter sites. A typical PCR would include 5 ml of phage DNA dilution, 6 ml of PCR mix (0.833 mM each dNTP, 4.17 mM Tris-HCl, 41.67 mM NaCl, 2.08 mM MgCl 2 and 0.417 mM 2-mercaptoethanol), 100 ng of each primer and 1 unit Taq DNA polymerase (Boehringer Mannheim, Corp., Indianapolis, IN) in a total volume of 25 ml. PCR conditions consisted of denaturation at 948C, 5', followed by 35 cycles of 948C, 1 min, 30 s; 608C, 1 min; 728C, 1 min and extension at 728C, 7 min. The ampli®ed products were then cloned into the pCRII vector using the TA cloning kit (Invitrogen Co.). Colonies positive for inserts were identi®ed using PCR. Sequence analysis of the clones was performed as previously described .
Northern analysis mRNA (10 mg) from various cell lines was electrophoresed on a 0.8% denaturing formaldehyde gel (Sambrook et al, 1989) . The RNA was transferred to Hybond N + membrane (Amersham Corp.) by capillary action using 106SSC. The membrane was then baked in a vacuum oven at 808C for 1 ± 2 h or crosslinked using a UV crosslinker. Prehybridization was performed from 6 h to overnight at 658C in 66SSPE, 0.1% SDS, 106Denhardt's solution and 100 mg/ml sonicated salmon sperm DNA. Radioactive double-stranded probes were prepared by random priming (Feinberg and Vogelstein, 1984) . Hybridization was performed in the same solution at 658C overnight. Washing conditions consisted of 26SSPE, 0.5% SDS, 10 min at room temperature followed by 16SSPE, 0.5% SDS at 658C, 15 min and, if needed, 0.26SSPE, 0.1% SDS at 658C for 15 min. The moist membrane was heat-sealed in a plastic bag then exposed to Kodak XAR ®lm with intensifying screens at 7808C.
